#USA #San Francisco #Hormone Health #Mira #Ultra4

Mira Unveils Ultra4™: A Revolutionary At-Home Hormone Monitor for Women’s Health

In a significant breakthrough for women's health, Mira has introduced Ultra4™, the first at-home hormone monitor that provides lab-quality insights into four essential hormones: FSH (Follicle Stimulating Hormone), LH (Luteinizing Hormone), E3G (Estriol Glucuronide), and PdG (Pregnanediol Glucuronide). This innovative device promises users accurate and comprehensive hormonal profiles, allowing them to understand their cycles like never before.

Understanding Ultra4™

The Ultra4™ system is designed for ease of use, requiring just a single wand and a 16-minute test to gather hormone data. This simplicity empowers individuals to gain insights not only about ovulation timing but also the strength and viability of ovulation itself. This advancement is crucial for those tracking fertility, navigating the changes of perimenopause, or simply wanting a better grasp of their overall hormonal health.

“With Ultra4™, we are transforming the way women interact with their hormonal health,” said Sylvia Kang, the CEO and Co-founder of Mira. “Our technology delivers the precision that was previously only available in clinical settings directly to women’s homes.”

Features of Ultra4™

Ultra4™ stands out in the market with several innovative features that include:

• - 4D Ovulation Profiling™: This advanced assessment tool not only tracks ovulation timing but evaluates its strength and viability, offering deeper insights.
• - Egg Prep Scan™: A new feature that allows users to observe follicle development earlier in their cycle, providing valuable information about reproductive health.
• - Hormonal Fingerprint™: This function helps users establish a personal hormonal baseline to identify any imbalances in their cycles.
• - Cycle Balance Analysis: It evaluates hormone ratios, promoting overall harmony within the hormonal environment.
• - Egg Count Intelligence™: Through monitoring FSH levels, this feature sheds light on ovarian reserve, crucial for those assessing fertility.

The Technology Behind Ultra4™

Mira’s Ultra4™ utilizes cutting-edge fluorescent technology akin to that found in clinical laboratories, boasting up to seven times the accuracy of traditional fertility monitors on the market. This high level of precision ensures that users receive reliable data they can trust, making informed decisions about their reproductive health.

With the accompanying AI-powered app, users can conduct tests at their convenience, anytime during their cycle, or even multiple times daily if needed. This flexibility allows for tailored insights that cater specifically to the user’s unique hormonal patterns.

Addressing Key Gaps in Women’s Health

Mira aims to bridge a significant gap in women's health by providing accessible, real-time hormone data that has been largely unavailable. The company is not only focused on fertility but is also expanding its vision to encompass a comprehensive hormone health platform. Future developments may include wearable technology for ongoing multi-hormone monitoring, ultimately creating a revolutionary resource for women in all stages of their health journeys.

“Ultra4 is a reflection of our mission to empower women with the information they need to navigate their health confidently,” Kang added. “We believe that understanding hormonal health is vital for every woman.”

About Mira

Founded in 2015 and based in San Francisco, Mira's mission is to enhance women's hormonal health through innovative technology and comprehensive care solutions. By supplying data-driven hormonal health products, Mira aims to enable women to make informed decisions throughout every phase of their lives—from menstruation to menopause.

To learn more about Mira and the Ultra4™, please visit miracare.com.